Recently, Anhui Poly Pharm. Co., Ltd. and the School of Chemistry and Chemical Engineering, Anqing Normal University sign a graduate employment base cooperation agreement.
On the one hand, from the perspective of enterprises, this helps Anhui Poly to accurately match chemical majors according to business needs, select talents, reduce pre-job training, and reduce human resource costs and improve production efficiency through resource sharing. On the other hand, from the social point of view, Anhui Poly actively and accurately docks with universities, widely takes the platform to promote employment, and improves the employment rate of students, highlighting the humanistic care and social responsibility of the enterprise.
Introduction of the School
Anqing Normal University, referred to as AQNU, is an excellent university evaluated by the Ministry of Education for undergraduate teaching and one of the first units in China with the right to award bachelor's degrees. The university has the right to grant master's degrees, and has been selected as the project of the second phase of the "Central and Western Universities Basic Capacity Construction Project", the first batch of pilot universities of the "Data China" 100 Schools Project, and the national college students' cultural quality education base. In 2019, the university officially became a provincial doctoral project construction unit in Anhui Province. Chemistry major was founded in 1977, affiliated to the School of Chemistry and Environmental Science, is one of the earliest majors in Anqing Normal University.
The chemistry major has passed the second level certification of the Ministry of Education. The college has a strong faculty, with professors, associate professors and other high-level teachers, as well as rich teaching and research resources. School of Chemical Engineering of Anqing Normal University has cultivated a large number of outstanding talents for the country and society.
Foreign Cooperation
Anhui Poly has always adhered to the strategy of characteristic APIs and multi-dimensional common development, and is committed to innovative breakthroughs in the field of medicine. To achieve this goal, the company actively seeks to establish a close exchange and cooperation mechanism with external universities and enterprises, so as to comprehensively enhance the comprehensive strength of talent, technology and resources.
First of all, in terms of talent training, the company attaches importance to the construction of talent team, and establishes a talent transfer mechanism with colleges and universities to attract more outstanding graduates to join the company. It is based on this goal that the graduate employment base cooperation is reached with the School of Chemistry and Chemical Engineering of Anqing Normal University.
Secondly, at the technical level, Anhui Poly has launched industry-university-research cooperation with universities and enterprises to jointly carry out key technological research to improve the research and development level and product quality of APIs.
Finally, in terms of resource integration, Anhui Poly shares upstream and downstream resources of the industrial chain with partners to achieve complementary advantages and common development. In the increasingly competitive environment of the API market, through the integration of high-quality resources to improve industrial concentration, and further consolidate the market position.
Anhui Poly
Anhui Poly Pharm. Co., Ltd., founded in 2018, is located in Anqing National High-tech Industrial Development Zone. It is a specialist supplier of active raw materials, providing high quality chemosynthetic and biosynthetic specialty raw materials to the pharmaceutical, healthcare and skincare sectors worldwide.
At present, the company has 3 API production workshops, 10 production lines and 357 multi-functional equipment that meet the GMP standards of Europe, the United States and China. Relying on strong research and development capabilities and technology transformation capabilities, the company has completed the commercial development and production of contrast agents (Gadoterate Meglumine, Gadoteridol, Gadobutrol, Ioversol, Iopamidol, Iodixanol), synthetic biology (ectoin, salidroside), antitumor (cyclophosphamide), other API (Magnesium hydroxide, Apremilast, Voriconazole, Memantine hydrochloride), and other pharmaceutical excipients (DOTA),SBE-β-CD, Calteridol calcium).
In the future, Anhui Poly will adhere to the global strategy of "advanced high-end manufacturing, facing domestic and international markets", and continue to develop more and better drugs, so that the Chinese people can use high-quality drugs exported to Europe and the United States.
